News | News By Subject | News by Disease News By Date | Search News

Diabetes, Type 2 (non-insulin dependent) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Agreement Reached After Novo Nordisk A/S (NVO) is Accused of Disguising Salespeople and Dealing Kickbacks     5/2/2017
This Bay Area Biotech is Being Wooed by Drug Giant Novo Nordisk A/S (NVO)     3/10/2017
Pfizer (PFE) Quietly Kills 3 Pipeline Programs     2/2/2017
Alphabet's Verily, Sanofi (SNY) Launch $500 Million Onduo, Joint Venture to Open New HQ in Kendall Square     9/13/2016
With Hopes of Bolstering Sanofi (SNY)’s Sagging Diabetes Sector, Announces FDA Approval of Adlyxin in U.S.     7/28/2016
FDA Panel Narrowly Backs Cardiovascular Claims for Boehringer Ingelheim, Eli Lilly (LLY)'s Jardiance     6/29/2016
Sanofi (SNY)'s New Diabetes Combo Nails Late-Stage Goals     6/13/2016
Sanofi (SNY) Snags FDA Panel's Support for New Once-Daily Diabetes Combo iGlarLixi     5/26/2016
Oramed (ORMP)'s Oral Insulin Succeeds In Phase IIb Type 2 Diabetes Trial     5/18/2016
Intarcia Touts Large Phase III Trial Diabetes Data, Bags $75 Million     5/6/2016
Eli Lilly (LLY) Abandons Development of Transition Therapeutics (TTH.TO)' Diabetes Candidate TT401     4/19/2016
Sanofi (SNY) Pays $20 Million Milestone and Redeems Priority Review Voucher for Zealand Pharma  (ZEAL.CO)’s LixiLan     12/23/2015
FDA Clears Eli Lilly (LLY)'s Diabetes Drug Basaglar     12/17/2015
Biodel (BIOD) Announces Removal of Partial FDA Clinical Hold on Phase IIb Study 3-250     10/12/2015
SoCal's Elcelyx Therapeutics Reels in $40 Million     10/1/2015

News from Around the Web
FDA Warns of Leg, Foot Amputations With Johnson & Johnson (JNJ)'s Diabetes Med, Invokana     5/17/2017
New Test IDs Diabetics Who Are At High Risk Of Kidney Failure, Joslin Diabetes Center Study Reveals     4/19/2017
Bay Area's Livongo Rakes in $52.5 Million     3/17/2017
Long Naps Linked To Diabetes, University of Tokyo Study     9/15/2016
Early And Late Menopause Can Increase Risk Of Type 2 Diabetes, Kaiser Permanente Study     7/27/2016
Cycling May Help Lower Type 2 Diabetes Risk, University Of Southern Denmark Study     7/13/2016
Sex Could Play A Role In Type 2 Diabetes Treatment... But Not In The Way You Think, IRCM Study     7/6/2016
Gray Matter Changes In Brains Of Teenagers With Type 2 Diabetes, Cincinnati Children's Hospital Medical Center Scientists Reveal     6/15/2016
GI Windows Anastomosis System For Treating Type 2 Diabetes     6/2/2016
Eating Junk Food Just As Harmful To Kidneys As Diabetes, Anglia Ruskin University Study     5/10/2016
More Blood Vessels In Adipose Tissue May Alleviate Type 2 Diabetes, University of Helsinki Study     4/25/2016
How Depression May Boost Your Type 2 Diabetes Risk, McGill University Study     4/15/2016
Long Naps, Daytime Sleepiness Tied To Heart Risks, University of Tokyo Reveals     3/28/2016
Thirdhand Smoke Doubles Your Diabetes Risk, University of California, Riverside Study     3/3/2016
Molecular Link Between Psychiatric Disorders And Type 2 Diabetes Discovered, University of Massachusetts Medical School Scientists Reveal     2/8/2016

Press Releases
Valeritas’ V-Go Wearable Insulin Delivery Device Provided Significant And Sustained A1C Reductions And Achieved A1C Glycemic Targets In Patients With Type 2 Diabetes     5/5/2017
Poxel (POXEL.PA) Rockets After Diabetes Med Hits Goals In Mid-Stage Study     5/4/2017
New Test IDs Diabetics Who Are At High Risk Of Kidney Failure, Joslin Diabetes Center Study Reveals     4/19/2017
SCIENCE CHINA Life Sciences English Edition Publishes Domestic Type 2 Diabetes Research Findings     4/12/2017
Spitfire Pharma Will Present Body Weight, Liver Weight And Glucose Regulation Data On The GLP-1/Glucagon Dual Agonist SP-1373 At American Diabetes Association's 77th Scientific Sessions     4/11/2017
Poxel SAS Announces Positive Results For Thorough QT Safety Clinical Study Of Imeglimin     3/21/2017
AstraZeneca PLC (AZN)'s Diabetes Med Cuts Death Rates in Real-World Trial     3/20/2017
Sanofi (SNY) And Voluntis Announce A Global Alliance To Deliver Digital Insulin Titration Solutions For People With Type II Diabetes     3/14/2017
Virta Health Launches in the Bay Area With $37 Million     3/8/2017
Merck & Co. (MRK), Pfizer (PFE)'s 4-Year Diabetes Alliance Pays Off With FDA, EMA Filings     3/7/2017
Merck & Co. (MRK) And Pfizer (PFE) Announce FDA And EMA Filing Acceptances Of Three Marketing Applications For Ertugliflozin-Containing Medicines For Adults With Type 2 Diabetes     3/6/2017
Quest Diagnostics (DGX) And American Diabetes Association To Help Identify People At Risk For Type 2 Diabetes     3/6/2017
FDA Grants Orphan Drug Designation To ProMetic Life Sci (PFSCF.PK)'s PBI-4050 Drug For The Treatment Of Alström Syndrome     3/3/2017
AstraZeneca PLC (AZN) Release: FDA Approves Once-Daily QTERN (Dapagliflozin And Saxagliptin) Tablets For Adults With Type-2 Diabetes     2/28/2017
Enrollment Completed In Ligand (LGND)’s Phase II Trial Of LGD-6972 In Type 2 Diabetes     2/27/2017